does glp 1 cross the blood brain barrier Repurposing glucagon-like peptide-1 receptor agonists for treatment of neurodegenerative disorders Impact of GLP-1 receptor agonists

The excess AGEs increases chronic inflammation and bone resorption in diabetics

Mounjaro (tirzepatide) tends to produce greater weight loss in clinical studies and targets two receptors versus one

Since muscles contribute to energy expenditure at more than twice the rate of fat tissue, the reduction in muscle and other lean mass accompanying fat loss results in lower energy expenditure after weight reduction

Foundayo is primarily metabolized via hepatic CYP3A4, and the dose should not exceed 9 mg when taken with strong CYP3A4 inhibitors

But, its key to think about the risks too

Every month, theres a new study showing another benefit for something like fatty liver disease, addiction or sleep apnea, Kim said